The Impact of OPIUM and Its Derivatives on Cell Apoptosis and Angiogenesis

Document Type : Review


1 Urology Research Centre, Tehran University of Medical Sciences, Tehran, Iran

2 Cancer Research Centre, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

3 Paediatric urology Department, Tehran university of Medical Sciences, Tehran, Iran

4 Genomic Research Centre (GRC), Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran


Opium is an opiate substance that significantly affects human physiology and behavior. Ancient priests used opium as a powerful healing drug, and many medical texts have referred to opium as medication, especially during the nineteenth century. In the old days, the medical use of opium was widespread and was called "God's medicine." On the other hand, understanding the molecular pathway of opium function within cells is essential from pathophysiological views and clinical applications. The current literature shows that opium can initialize cell death by activating apoptotic events, which in turn induces cascade pathways of angiogenesis. In this review article, we attempt to investigate the effects of opium on cell apoptosis and angiogenesis.


  • Opium can initialize cell death by activating apoptotic events, which in turn induces cascade pathways of angiogenesis.
  • Opium and its derivates, such as morphine, codeine, noscapine, and papaverine, increase the rate of cellular apoptosis and angiogenesis through various mechanisms in most cells.
  • Opium and its derivates can disrupt an organ’s normal function.


Main Subjects


Opium, with a bitter taste, is an opiate substance derived from a plant with the scientific name of Papaver Somniferous from the Papaveraceous family. Opium’s natural and synthetic derivatives significantly affect human physiology and behavior (1, 2). The opium plant’s ovary contains poppy seeds with an oval shape and pink petals. Farmers seep through the immature ovary when the petals wither using a traditional blade and let the secretion coagulate in the vicinity of the air. After a full day and night, the opium gum turns brown and sometimes black. The gum remains attached to the outer wall of the ovary, so the farmers can scrape and collect it easily. Opium has different usual names, such as Papaver Somniferous and Poppy in English and Khashkhash in Persian. The original name comes from the Greek word “Theriaca.” In Arabic, it is called Teryaqi, abion, and opium, while abion is derived from the Greek root opium. It is a substance with a wide variety of pharmacological and pathological effects due to its twenty types of alkaloids and seventy other compounds (3). Opium is a natural latex with 12% morphine. Physically, opium comes in various forms naturally (Raw, juice, burnt opium), semi-synthetic (Medications such as morphine, codeine, hydrocodone, oxycodone), and fully synthetic (Drugs like fentanyl, fentanyl analogs, tramadol, and mostly methadone) (Figure1).



 Figure 1. Molecular structures of opium alkaloids


The leftover material after smoking is a brown and shiny substance called "burnt opium," which is soluble in the water to reuse. Addicts dissolve the burnt opium in water and boil it for reusing. Then it is passed through a strainer to produce pulp. Consumers reheat the pulp to make a thick brown paste called "juice". This juice is much more effective than opium and is consumed orally or by smoking.


History of opium

The Sumerian, Greek, Egyptian, Persian, Assyrian, Roman, Minoan, Arab, and Indians have used opium since 5000 BC. Opium has been cited and explained in the ancient medical books by Persian physicians like the famous Avicenna as an analgesic and antitussive. It was suggested to manage neuromuscular disturbances, sexual dysfunction, and hypnosis. Muhammad ibn Zakariya al-Razi another Persian physician, and Abu al-Qasim al-Zahrawi the Andalusian ophthalmologist, also recommended opium as an anesthetic for surgical procedures. In the 14th century, the Ottoman Empire recruited opium to manage diseases such as sciatica pain, migraine, and other occasions. Medical use of opium in the 19th century was prevalent, and users called it the "drug of God." The first pure, naturally derived medicine and the first to be commercialized opium was in the 16th century. After that, Thomas Sydenham, known as Plato of England, developed a new drug from opium in the 17th century, which was later called morphine.


Opium compounds and their function in different body tissues

Several studies have shown that opium interferes with the symptoms of prostate cancer, so it may delay the early detection of this disease. Opium usage was related to a remarkable decline in the prostate-specific antigen (PSA) serum level (4). It has been observed that opium causes changes in male sex hormones and function through testicular tissues, including Sertoli cells and seminiferous tubules, resulting in spermatogenesis and fertility problems (5-7). There is some evidence that the diameter of the sperm-producing tubes becomes narrower in opium addict patients (8). Opium can change the normal pituitary system function, and daily methadone intake for 5 to 10 days could significantly decrease the weight of genitals in rats. It is found that opiates had an inhibitory effect on Gonadotropin-releasing hormone (GnRH)  secretion and remarkably reduced testosterone secretion(9). Ranji and his colleagues showed that the semen analysis of heroin addicts was completely abnormal due to heroin toxicity in the reproductive system (8).

On the other hand, morphine consumption can cause structural abnormalities in gastrointestinal and kidney tissue. Inhalation of opium can increase the production of inflammatory cytokines; also, it may cause hypoxia by the elevation of carboxy-hemoglobin, which increases erythropoietin production, followed by polycythemia with iron overload. Using opium directly or indirectly affects the function of various tissues in the body, including white blood cells. Although blood cells have a short lifespan, they have been shown to have opioid receptors (σ, µ, and κ), so they can respond to endorphins (β-endorphin, dynorphin, Met-enkephalin) (10, 11). The occupation of opioid receptors by endorphins or opioids directly affects the levels of cytokines, cell growth, cell division, and differentiation of peripheral white blood cells. This, in turn, may cause hepatic failure. Mazumder and colleagues showed that fatty liver and liver fibrosis were more prevalent among opium abusers (12). There is evidence of the relationship between oesophageal cancer and polyneuropathy, both common in opium abusers (13, 14). Some researchers also found a relationship between opium consumption and oesophageal, laryngeal, and bladder cancers (14, 15).

The negative impact of opium on the immune system can be explained by decreasing Interleukin-2 (IL-2) at the heterogeneous nuclear RNA (hnRNA) (11, 16), which has been scientifically proven. A slight increase in IL-2and a significant decrease in IL-10happens in addicted ones, which affects their immunity against infections. In these people, the process of differentiation in cell-assisted lymphocytes (Th) is switched from Th2 to Th1(11, 17). Bhat et al. have concluded that an increase in TGF-β1 occurs in opium users, which is a result of morphine intake, and it leads to the initiation of the planned death (apoptosis) of the macrophages (18). The TGF-β1, a transforming growth factor-beta superfamily of cytokine (Th3) (19, 20), is involved in the regulation of the immune system (19, 21), macrophage apoptosis (18), and the suppression of TH1 (20). Malik et al., have shown that if morphine is exposed to the bone marrow, it causes cell death apoptosis in 20% of bone marrow cells, which might be another reason for a decrease in the number of red blood cells among addicts (22). Therefore, opium smokers have higher levels of Th2 and Th3-helping lymphocytes than normal people. This means that their Th1-assisted lymphocytes are less effective and are more likely to be damaged during infection because of the lower activity of Th2 and higher activity of Th1. Morphine can increase platelet adhesion and aggregation; and intracellular calcium (23, 24), which results in the formation of plaques. This process results in a significant decrease in platelets, so opium can lead to hemolysis.  

The use of opium causes changes in the immune responses to stresses that can damage tissues via alteration in the secretion of cytokines (25). Similarly, other opioid derivatives such as morphine, noscapine, papaverine, and codeine, the major constituents of opium, can also affect the production and release of cytokines, including interleukin-4 (IL-4) and interferon-gamma (IFN-γ). These can also act as either stimulants or inhibitors of inflammation (25). A 2015 study by Asadi Karam et al., has shown that opium can stimulate the secretion of pro-inflammatory cytokines INF-γ, Tumor Necrosis Factor-alpha (TNF-α) in humans that was able to suppress the secretion of anti-inflammatory cytokines like IL-4 and IL-10 (26). Another research by Lashkari Zadeh et al. studied the effect of opium on the level of inflammatory cytokines in male rats after surgery, which showed that opium addiction significantly increased the level of INF-γ (27) pro-inflammatory cytokines and decreased the levels of IL-4 (28)  anti-inflammatory cytokines after surgery (29).

C-reactive protein (CRP) is one of the acute phase proteins of inflammation and is used as an inflammatory marker in diagnosing inflammatory infections. Plasma CRP levels (30) can be a marker in the pathogenesis of cardiovascular diseases affecting the complement system. In bacterial and viral infections, active rheumatic fever, acute myocardial infarction, stroke, rheumatoid arthritis, etc., plasma CRP levels are increased in the serum of individuals (31). It has been observed that opium consumption increases the levels of cytokines, including IL-17, IL-10, and TNF-α, and inflammatory markers CRP, C3, and C4 complement and immunoglobulin A (31, 32). A study on opium-addicted men also found that serum levels of IL-4, and INF-gamma, were lower than in healthy cases, while levels of TGF-β and IL-6 were higher  (25). 


Opium and apoptosis


Apoptosis is a highly conserved pathway that causes programmed cell death and is essential for the balance of body tissues. This mechanism is fundamental to many of the body's normal physiological processes, including embryo formation, normal tissue development, and immune responses  (33). This pathway possesses a variety of interfaces between intracellular cascades and is generally divided into two Extrinsic and Intrinsic pathways (Figure 2).


Figure 2. Two Extrinsic and Intrinsic pathways of apoptosis


Opium causes cell death through apoptosis, and research has shown that apoptosis massively happens in the brain and liver of opium-addicted rats (34). Opium has been observed to stimulate apoptosis through both extrinsic and intrinsic pathways in Jurkat cells. Although it increases the expression of some anti-apoptotic molecules that might be a normal reflection of the cell’s resistance against death, the use of opium derivate as a treatment can stimulate apoptosis in liver and brain cells in Rat’s Jurkat cells (35).

The extrinsic pathway starts with stimulating death receptors (such as TNF-R, FAS) and then activating Caspase 8 and its downstream effectors. However, this cascade can be inhibited by (CFILP) and (IAPs). The intrinsic pathway is stimulated by environmental factors such as cellular stress, DNA damage, and hypoxia. It is followed by releasing cytochrome C from mitochondria, which functions as an electron shuttle in the respiratory chain and interacts with cardiolipin. Subsequently, Caspase 9 and other downstream caspases are activated in the early stages of apoptosis. These proteins destroy key cellular constituents, including structural and skeletal proteins and other major proteins, such as DNA repair enzymes (36). Apoptotic stimulating agents are BID, BAX, and BAD, while survivin and Bcl-2 proteins are anti-apoptotic. The Bcl-2 protein family is a critical regulator of apoptosis within the mitochondrial outer membrane and can inhibit the internal pathway of apoptosis.

Also, it has been observed that opium addicts frequently suffer from infectious diseases due to poor immune responses (25, 32). Thus, it seems that opium can induce in-vivo and in-vitro apoptosis in immune cells through an unknown pathway (25).  It has been found that the expression level of pro-apoptotic molecule ABL1 was increased in Jurkat cells treated with opium. ABL1 is a cytoplasmic and nuclear tyrosine kinase protein involved in various cellular functions, including division, differentiation, adhesion, and response to cellular stress (37).

A study on Jurkat cells treated with opium showed that the mRNA expression level of pro-apoptotic molecules such as LTA, TP53BP2, BNIP3, TNFRSF1, Bcl-2, and NOD1 increased two-fold. Increased expression of BNIP3 and Bcl-2 levels is believed to trigger apoptosis in opium-treated cells. The TNF/TNFR1, LTA/TNFR1, and LTA/LTBR pathways also play significant roles in the initiation of apoptosis in the Jurkat cell line when exposed to opium. The apoptotic properties of opium-treated Jurkat cells lead the mRNA expression level of some anti-apoptotic molecules such as NOL3, Bcl-2, and DFFA to increase inside cells.

Opium also increases TP53 apoptotic properties by promoting its function rather than its expression. Also, the expression levels of caspase 3 (CASP3), CASP4, and CASP6 increase after treating cells with opium. It mainly induces cellular apoptosis through the extrinsic pathway, which is led by the expression of TNFRSF1A and LTA molecules.


Noscapine is an opium alkaloid with chemical similarity to podophyllotoxin and colchicine, which keeps cells in the mitosis stage leading towards apoptosis.  Previous studies have shown the effects of alkaloids such as morphine, heroin, codeine, noscapine, and papaverine on apoptosis (35). It has been shown that noscapine could effectively inhibit the proliferation of LoVo cells in vitro and enhance the anticancer effects of several chemotherapy drugs by inducing apoptosis in malignant cells without any detectable toxicity to the normal cells. It has been shown that Bax and cytochrome c (Cyt-c) gene expression, survivin and Bcl-2 gene expression, as well as caspase-3 and caspase-9 activation, are increased along with an increase in chromatin density and fragmentation. Noscapine induces apoptosis in colon cancer cells with mitochondrial pathways and halts phase M/G2 by causing chromatin condensation and nucleus scattering. It is believed that tumorigenicity is also inhibited by noscapine (38).


Morphine and opioids, which are medically used as analgesic drugs, can bind to specific receptors in different tissues and induce apoptosis (39, 40). Morphine has the highest pharmacological effects on the central nervous system and gastrointestinal tract (41). However, some other researchers suggest a protective role for morphine (42). It has been observed that morphine could cause the death of neurons by decreasing the level of intracellular dopamine, which is associated with increased cellular metabolism and oxidative damage to the cells (43). Repeated injections of opioids such as morphine alter the expression of genes in different areas of the brain that is resulted from the activation of multiple transcription factors in response to morphine sensitivity and resistance (44).

There are many extra- and intracellular signaling substances that induce apoptosis through the receptors at the surface of cells (44), and morphine is one of them (41, 45). Studies have also shown that long-term treatment with morphine in mice led to changes in apoptotic factors. These changes include increased levels of the FAS receptor (pro-apoptotic factor) and decreased levels of Bcl-2 (anti-apoptotic factor), especially in the brain (41). Injection of morphine has also been shown to increase pro-apoptotic proteins (caspase-3, Cysteinyl Aspartate-Specific Protease, and Bax and a decrease in Bcl-2 protein (anti-apoptotic) in rat spinal cord (46) (Figure 3).  




Figure 3. Morphine and its various functions in the cell: Morphine can have an inhibitory effect on cellular immune response in several ways: 1. by inducing anti-inflammatory cytokines, 2- With inhibitory effect on pro-inflammatory cytokines such as interleukin 2, interleukin 6, and TNF, and 3- With the effect of inhibiting the activity of NK. Morphine, on the other hand, can induce angiogenesis by inducing VEGF and COX2 and inhibiting P38 MAPK. Morphine can positively affect cytochrome c and caspase 3 and 9 by inducing P53, P21, Bax, and Fas cascading pathways and inducing JNK, ROS, Bim/Bcl2, and directing the cell toward apoptosis. Morphine also affects the matrix of metalloproteinases and ECM by reducing and inhibiting nitric oxide and initiating cell metastasis. NK: Natural Killer Cells; VEGF: Vascular endothelial growth factor; COX2: Cyclooxygenase 2 


The Effect of Morphine on Alteration of Bax/ Bcl-2 Apoptosis Factor

Bcl-2 Family proteins (B-cell lymphoma 2) are a group of proteins that include anti-apoptotic (Bcl-2, Bcl- XL) and pro-apoptotic (Bcl-2 associated x protein, Bax) factors. The cell's sensitivity to apoptosis is regulated by balancing between pro-apoptotic and anti-apoptotic factors of the Bcl-2  family (33, 47). In this system, the Bcl-2 protein with a 28-kDa anti-apoptotic unit prevents cell death. It is observed that the ratio of Bax/ Bcl-2 proteins is increased by morphine. Long-term treatment of morphine increases pro-apoptosis protein factor FAS receptor (pro-apoptotic factor) and decreases protein factor Bcl-2  (anti-apoptotic factor), which together induce apoptosis in rat’s brain (41).

Morphine and DAMGO (D-Ala, N-MePhe, Gly-Ol-enkephalin), a synthetic opioid peptide with high μ-opioid receptor specificity, have been shown to induce apoptosis in T lymphocytes by a decrease in Bcl-2 anti-apoptotic protein expression plus an increase in pro-apoptotic Bax expression (48). It seems that via Delta Receptors, Opioids inhibit FADD (Fas-Associated protein with Death Domain) by activating the signaling axis of ERK1/2 and blocking the vital cell signaling axis. At the same time, no inhibition was observed in Delta-free mice (49), indicating the role of Delta receptors.    


Effect of Morphine on Caspase-3 Apoptosis Factor Change

It has been found that morphine significantly increases fractured caspase levels, while Caspase-3 is one of the active caspases, which plays an important role in the internal and external pathways of apoptosis. PARP (Poly ADP ribose polymerase) is a protein that binds to single-stranded DNA and plays a role in its repair process. PARP has 24, 89, and 116 Da subunits that subunits 24 and 89 induce apoptosis by activating caspase-3. PARP is a substrate of specific caspases, such as caspase-3 and Caspase-3, that can decompose PARP in its active form. The amount of PARP protein significantly increases when morphine is given.


Morphine and angiogenesis

Angiogenesis means the creation of new capillaries from existing vessels. Angiogenesis is a physiological regeneration process mediated by a balance between angiogenesis promotor and inhibitor factors. In some malignant conditions, the balance is lost, and tumor growth or metastasis happens. Koodie et al., showed that morphine could repress vascular endothelial growth factor (VEGF) transcription and provokes the secretion of transcription factor1 alpha (HIF-1alpha)/p38MAPK via a hypoxia-inducible pathway in mouse Lewis lung carcinoma cells (LLCs)(50) (Figure 4).  


Figure 4. Mechanisms of tumor angiogenesis: Morphine directly affects COX-2 and the production and secretion of prostaglandins, increases VEGF and induces angiogenesis. VEGF: Vascular endothelial growth factor; COX2: Cyclooxygenase 2


Morphine induces PDGF/PDGFR/c-Src signaling pathway in angiogenesis followed by activation of AKT and ERK1/2 molecule, which is a result of releasing and activating endothelial platelet-derived growth factor (PDGF-BB) receptors. It has been found that c-Src kinase can activate VEGF and its receptor (VEGFR), which is followed by the initialization of the angiogenic signaling pathway of up-regulated VEGFR that, in turn, results in angiogenesis (51). on the other hand, morphine amplifies tumor angiogenesis by enhancing the strength of mast cells. Previous studies have shown that the angiogenic potential of cells in prostaglandin E2 (PGE2) was improved, resulting in VEGF synthesis. Morphine can also cause over-expression of the inflammatory cyclooxygenase 2 (COX-2) and release of PGE2 from the tumor cells ending in the production of tumor vessels (51). However, a study by Sabrina Bimonte and colleagues showed that morphine improved the angiogenesis and progression of human breast carcinoma cells in a xenograft mouse model (52) (Figure 5).


Figure 5. Morphine-induced angiogenesis by the signaling pathway of PDGF/PDGFR/c-Src



This review study concludes that opium and its derivates, such as morphine and noscapine, increase cellular apoptosis, provoke angiogenesis through various mechanisms, and disrupt an organ’s normal function, especially in the brain and gastrointestinal system.


Authors’ Contribution

All authors had an equal contribution.



 Special thanks to the urology Research Center, Tehran University of Medical Sciences (TUMS).



There is no funding.


Conflict of interest

All authors declare that there is not any kind of conflict of interest.


Ethical Statement

Not applicable.


Data availability

 Information, data, and photos will be provided on request.



CASP3           Caspase 3 COX-2    Cyclooxygenase 2

CRP               C-reactive protein

Cyt-c              Cytochrome c

DAMGO        D-Ala, N-MePhe, Gly-Ol-enkephalin

FADD            Fas-associated protein with death domain

GnRH            Gonadotropin-releasing hormone

hnRNA          Heterogeneous nuclear RNA

IFN-γ            Interferon-gamma

 IL                 Interleukin

LLCs             Lewis lung carcinoma cells

PARP            Poly ADP ribose polymerase

PDGF           Platelet-derived growth factor

PGE2            Prostaglandin E2

PSA              Prostate-specific antigen

TGF-β1        Transforming growth factor-beta

TNF-α          Tumor necrosis factor-alpha

VEGF          Vascular endothelial growth factor

VEGFR        Vascular endothelial growth factor receptor

1.            Mohammadi A, Darabi M, Nasry M, Saabet-Jahromi M-J, Malek-Pour-Afshar R, Sheibani H. Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits. Experimental and toxicologic pathology. 2009;61(2):145-9.
2.            Mohammady G, Darabi-Amin M, javad Sabet-Jahromi M, Sheibani H, Nasry M, Puor–Afshar RM. EFFECT OF OPIUM ADDICTION ON LIPID PROFILE AND ATHEROSCLEROSIS AMONG NORMAL AND HYPERCHOLESTEROLEMIC RABBITS. Journal of Diabetes and Metabolic Disorders. 2007;6:3.
3.            Karam GA, Reisi M, Kaseb AA, Khaksari M, Mohammadi A, Mahmoodi M. Effects of opium addiction on some serum factors in addicts with non‐insulin‐dependent diabetes mellitus. Addiction biology. 2004;9(1):53-8.
4.            Hosseini SY, Amini E, Safarinejad MR, Soleimani M, Lashay A, Farokhpey AH. Influence of opioid consumption on serum prostate-specific antigen levels in men without clinical evidence of prostate cancer. Urology. 2012;80(1):169-73.
5.            Bolelli G, Lafisca S, Flamnigni C, Lodi S, Franceschetti F, Filicori M, et al. Heroin addiction: relationship between the plasma levels of testosterone, dihydrotestosterone, androstenedione, LH, FSH, and the plasma concentration of heroin. Toxicology. 1979;15(1):19-29.
6.            El-Shoura S, Aziz MA, Ali M, El-Said M, Ali K, Kemeir M, et al. Andrology: Deleterious effects of khat addiction on semen parameters and sperm ultrastructure. Human Reproduction. 1995;10(9):2295-300.
7.            Banerjee A, Pakrashi A, Chatterjee S, Ghosh S, Dutta S. Semen characteristics of tobacco users in India. Archives of andrology. 1993;30(1):35-40.
8.            Ragni G, De LL, Gambaro V, Di RP, Bestetti O, Recalcati F, et al. Semen evaluation in heroin and methadone addicts. Acta europaea fertilitatis. 1985;16(4):245-9.
9.            Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. The Journal of Pain. 2002;3(5):377-84.
10.          Bidlack JM. Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol. 2000;7(5):719-23.
11.          Roy S, Charboneau RG, Barke RA. Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model. Journal of neuroimmunology. 1999;95(1-2):107-14.
12.          Mazumder DG. Effect of chronic intake of arsenic-contaminated water on liver. Toxicology and applied pharmacology. 2005;206(2):169-75.
13.          Kalant H. Opium revisited: a brief review of its nature, composition, non‐medical use and relative risks 1. Addiction. 1997;92(3):267-77.
14.          Hosseini SY, Safarinejad MR, Amini E, Hooshyar H, editors. Opium consumption and risk of bladder cancer: a case-control analysis. Urologic Oncology: Seminars and Original Investigations; 2010: Elsevier.
15.          Mousavi MRA, Damghani MA, Haghdoust AA, Khamesipour A. Opium and risk of laryngeal cancer. The Laryngoscope. 2003;113(11):1939-43.
16.          Pacifici R, di Carlo S, Bacosi A, Pichini S, Zuccaro P. Pharmacokinetics and cytokine production in heroin and morphine-treated mice. International journal of immunopharmacology. 2000;22(8):603-14.
17.          Roy S, Wang J, Gupta S, Charboneau R, Loh HH, Barke RA. Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. Journal of neuroimmunology. 2004;147(1-2):78-81.
18.          Bhat RS, Bhaskaran M, Mongia A, Hitosugi N, Singhal PC. Morphine‐induced macrophage apoptosis: oxidative stress and strategies for modulation. Journal of leukocyte biology. 2004;75(6):1131-8.
19.          Weiner HL. Induction and mechanism of action of transforming growth factor‐β‐secreting Th3 regulatory cells. Immunological reviews. 2001;182(1):207-14.
20.          Weiner HL. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes and infection. 2001;3(11):947-54.
21.          Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation ex vivo of TGF-β-producing regulatory T cells from CD4+ CD25− precursors. The Journal of Immunology. 2002;169(8):4183-9.
22.          Malik AA, Radhakrishnan N, Reddy K, Smith AD, Singhal PC. Morphine-induced macrophage apoptosis modulates migration of macrophages: use of in vitro model of urinary tract infection. Journal of endourology. 2002;16(8):605-10.
23.          Sheu J-R, Yeh G-C, Fang C-L, Lin C-H, Hsiao G. Morphine-potentiated agonist-induced platelet aggregation through α2-adrenoceptors in human platelets. Journal of cardiovascular pharmacology. 2002;40(5):743-50.
24.          Hsiao G, Shen M-Y, Fang C-L, Chou D-S, Lin C-H, Chen T-F, et al. Morphine-potentiated platelet aggregation in in vitro and platelet plug formation in in vivo experiments. Journal of biomedical science. 2003;10(3):292-301.
25.          Nabati S, Asadikaram G, Arababadi MK, Shahabinejad G, Rezaeian M, Mahmoodi M, et al. The plasma levels of the cytokines in opium-addicts and the effects of opium on the cytokines secretion by their lymphocytes. Immunology letters. 2013;152(1):42-6.
26.          Asadikaram G, Igder S, Jamali Z, Shahrokhi N, Najafipour H, Shokoohi M, et al. Effects of Different Concentrations of Opium on the Secretion of Interleukin-6, Interferon-γ and Transforming Growth Factor Beta Cytokines from Jurkat Cells. Addiction & health. 2015;7(1-2):47.
27.          Najafipour H, Beik A. The impact of opium consumption on blood glucose, serum lipids and blood pressure, and related mechanisms. Frontiers in physiology. 2016;7:436.
28.          Joukar S, Najafipour H, Malekpour-Afshar R, Mirzaeipour F, Nasri HR. The effect of passive opium smoking on cardiovascular indices of rabbits with normal and ischemic hearts. The open cardiovascular medicine journal. 2010;4:1.
29.          Lashkarizadeh MR, Garshasbi M, Shabani M, Dabiri S, Hadavi H, Manafi-Anari H. Impact of Opium Addiction on Levels of Pro-and Anti-inflammatory Cytokines after Surgery. Addiction & health. 2016;8(1):9.
30.          Ciulla TA, Rosenfeld PJ. Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. Current opinion in ophthalmology. 2009;20(3):158-65.
31.          Ghazavi A, Mosayebi G, Solhi H, Rafiei M, Moazzeni SM. Serum markers of inflammation and oxidative stress in chronic opium (Taryak) smokers. Immunology letters. 2013;153(1-2):22-6.
32.          Ghazavi A, Solhi H, Moazzeni SM, Rafiei M, Mosayebi G. Cytokine profiles in long-term smokers of opium (Taryak). Journal of addiction medicine. 2013;7(3):200-3.
33.          Elmore S. Apoptosis: a review of programmed cell death. Toxicologic pathology. 2007;35(4):495-516.
34.          Asiabanha M, Asadikaram G, Rahnema A, Mahmoodi M, Hasanshahi G, Hashemi M, et al. Chronic opium treatment can differentially induce brain and liver cells apoptosis in diabetic and non-diabetic male and female rats. The Korean Journal of Physiology & Pharmacology. 2011;15(6):327-32.
35.          Igder S, Asadikaram GR, Sheykholeslam F, Sayadi AR, Mahmoodi M, Arababadi MK, et al. Opium induces apoptosis in Jurkat cells. Addiction & health. 2013;5(1-2):27.
36.          Zhang Y, Chen Q, Yu L-C. Morphine: a protective or destructive role in neurons? The Neuroscientist. 2008;14(6):561-70.
37.          Wang JY. The capable ABL: what is its biological function? Molecular and cellular biology. 2014;34(7):1188-97.
38.          Yang Z-R, Liu M, Peng X-L, Lei X-F, Zhang J-X, Dong W-G. Noscapine induces mitochondria-mediated apoptosis in human colon cancer cells in vivo and in vitro. Biochemical and biophysical research communications. 2012;421(3):627-33.
39.          Hsiao P-N, Chang M-C, Cheng W-F, Chen C-A, Lin H-W, Hsieh C-Y, et al. Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways. Toxicology. 2009;256(1-2):83-91.
40.          Bryant L, Doyle T, Chen Z, Cuzzocrea S, Masini E, Vinci MC, et al. Spinal ceramide and neuronal apoptosis in morphine antinociceptive tolerance. Neuroscience letters. 2009;463(1):49-53.
41.          Boronat MA, García‐Fuster MJ, García‐Sevilla JA. Chronic morphine induces up‐regulation of the pro‐apoptotic Fas receptor and down‐regulation of the anti‐apoptotic Bcl‐2 oncoprotein in rat brain. British journal of pharmacology. 2001;134(6):1263-70.
42.          Qian L, Tan KS, Wei S-J, Wu H-M, Xu Z, Wilson B, et al. Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity. The Journal of Immunology. 2007;179(2):1198-209.
43.          Oliveira MT, Rego AC, Morgadinho MT, Macedo TR, Oliveira CR. Toxic effects of opioid and stimulant drugs on undifferentiated PC12 cells. Annals of the New York Academy of Sciences. 2012;965:487-96.
44.          Ammon‐Treiber S, Höllt V. Morphine‐induced changes of gene expression in the brain. Addiction biology. 2005;10(1):81-9.
45.          Greeneltch KM, Kelly-Welch AE, Shi Y, Keegan AD. Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism. The Journal of Immunology. 2005;175(8):4999-5005.
46.          Mao J, Sung B, Ji R-R, Lim G. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. Journal of Neuroscience. 2002;22(17):7650-61.
47.          Skommer J, Wlodkowic D, Deptala A. Larger than life: mitochondria and the Bcl-2 family. Leukemia research. 2007;31(3):277-86.
48.          Singhal PC, Kapasi AA, Reddy K, Franki N, Gibbons N, Ding G. Morphine promotes apoptosis in Jurkat cells. Journal of leukocyte biology. 1999;66(4):650-8.
49.          García-Fuster M-J, Miralles A, García-Sevilla JA. Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway. Neuropsychopharmacology. 2007;32(2):399.
50.          Koodie L, Ramakrishnan S, Roy S. Morphine suppresses tumor angiogenesis through a HIF-1α/p38MAPK pathway. The American journal of pathology. 2010;177(2):984-97.
51.          Ondrovics M, Hoelbl-Kovacic A, Fux DA. Opioids: modulators of angiogenesis in wound healing and cancer. Oncotarget. 2017;8(15):25783.
52.          Bimonte S, Barbieri A, Rea D, Palma G, Luciano A, Cuomo A, et al. Morphine promotes tumor angiogenesis and increases breast cancer progression. Biomed research international. 2015;2015.